Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-29T07:39:12.268Z Has data issue: false hasContentIssue false

SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study

Published online by Cambridge University Press:  24 February 2021

Athanasios Michos*
Affiliation:
1st Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Parthena Savvidou
Affiliation:
3rd Department of Pediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece
Garyfallia Syridou
Affiliation:
3rd Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Eirini Eleftheriou
Affiliation:
2nd Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Elias Iosifidis
Affiliation:
3rd Department of Pediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece
Ioanna Grivea
Affiliation:
Department of Pediatrics, School of Medicine, University of Thessaly, Larissa, Greece
Vana Spoulou
Affiliation:
1st Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Emmanouil Galanakis
Affiliation:
Department of Pediatrics, School of Medicine, University of Crete, Heraklion, Greece
George Syrogiannopoulos
Affiliation:
Department of Pediatrics, School of Medicine, University of Thessaly, Larissa, Greece
Maria Tsolia
Affiliation:
2nd Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Emmanuel Roilides
Affiliation:
3rd Department of Pediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece
Vassiliki Papaevangelou
Affiliation:
3rd Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
*
Author for correspondence: Athanasios Michos, E-mail: amichos@med.uoa.gr
Rights & Permissions [Opens in a new window]

Abstract

As most children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present with mild symptoms or they are asymptomatic, the optimal strategy for molecular testing it is not well defined. The aim of the study was to determine the extent and aetiology of molecular testing for SARS-CoV-2 in Greek paediatric departments during the first phase of the pandemic and identify possible differences in incidence, depending on the age group and geographical area. We conducted a nationwide study of molecular testing for SARS-CoV-2 of children in paediatric departments between March and June 2020. A total of 65 paediatric departments participated in the study, representing 4901 children who were tested for SARS-CoV-2 and 90 (1.8%) were positive. Most paediatric cases were associated with topical outbreaks. Adolescents 11–16 years had the highest positivity rate (3.6%) followed by children 6–10 years (1.9%). However, since the testing rate significantly differed between age groups, the modified incidence of SARS-CoV-2 infection per age group was highest in infants <1 year (19.25/105 population). Most children tested presented with fever (70.9%), respiratory (50.1%) or gastrointestinal symptoms (28.1%). Significant differences were detected between public and private hospitals regarding the positivity rate (2.34% vs. 0.39%, P-value <0.001). Significant variation in SARS-CoV-2 molecular testing positivity rate and incidence between age groups indicate discrepancies in risk factors among different age groups that shall be considered when ordering molecular testing.

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Introduction

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world causing a major pandemic. Differences in the epidemiology of coronavirus disease 2019 (COVID-19) between countries and age groups have been reported [Reference Gotzinger1, Reference Manti2]. Although paediatric COVID-19 is usually asymptomatic or mild, there is heterogeneity of clinical presentation and cases of severe disease requiring intensive care unit (ICU) hospitalisation or children developing multisystem inflammatory syndrome have been described [Reference Manti2Reference Radia4].

Although molecular testing for SARS-CoV-2 is the mainstay for specific diagnosis, health care systems are facing obstacles to organise, as the current testing capacity and availability cannot meet the unprecedented global demands for rapid, reliable and widely accessible molecular diagnosis [Reference Feng5]. Most published data on molecular testing of children for SARS-CoV-2 infection originate from China and limited data have been published from European countries [Reference Gotzinger1, Reference Dong6].

The optimal strategy for molecular testing in children to avoid transmission in families and in schools has not been well defined. The aim of the study was to determine the extent and aetiology of molecular testing for SARS-CoV-2 in Greek paediatric departments during the first phase of the pandemic and identify possible differences in incidence, depending on the age group and geographical area.

Patients and methods

A retrospective national multicentre observational cohort study of molecular testing for SARS-CoV-2 in paediatric patients was designed and conducted from the Hellenic Society for Pediatric Infectious Diseases (HELLESPID). An electronic questionnaire (available at: https://forms.gle/HsKLZVmgNXvNRCGp9) was sent in June 2020 to the two children's hospitals and all Greek public and private hospitals having paediatric departments regarding molecular SARS-CoV-2 testing of children and adolescents 0–16 years of age during the first 3 months of the pandemic (1st March–31st May 2020). Initial contact was either via e-mail or phone call, and one participant from each hospital was asked to fill in the questionnaire. The questionnaire included epidemiological data regarding molecular testing for SARS-CοV-2, accessibility to SARS-CοV-2 molecular testing and turnaround time for laboratory diagnosis. Any child with at least one nasal/pharyngeal swab specimen positive for SARS-CoV-2 as tested by real-time reverse-transcriptase polymerase chain reaction (RT-PCR) was defined as SARS-CoV-2 infection.

A second more detailed questionnaire including demographic data and clinical information as well as the reason for which the test was performed was sent to large public paediatric departments of Athens (n = 3) and Thessaloniki (n = 1). Calculation of modified incidence of SARS-CoV-2 infection per prefecture and per age group was estimated based on the age stratification data given by the Hellenic Statistical authority. In the modified incidence, only positive cases diagnosed in the hospitals were included in the calculation of the nominator of incidence while cases diagnosed through tracing of index cases were excluded.

Results

From the 73 hospitals with paediatric departments asked to participate, 65 (89%) responded. Of them, 60 were public and five were private institutions. The geographical distribution of participating hospitals is shown in Figure 1 (panel A). A total of 4901 children were tested for SARS-CoV-2 and 90 (1.8%) were positive. Most paediatric cases were associated with local outbreaks of SARS-CoV-2 infection in the adult population (Fig. 1, panel B). Significant variation of SARS-CoV-2 positivity rate by month was noted during the study period. More specifically in March 17/990 (1.7%) were tested positive, in April 42/1580 (2.7%) and in May 31/2331 (1.3%) (P-value: 0.008, chi-square test).

Fig. 1. Geographical distribution of the paediatric departments (n = 65) which participated in the national Greek paediatric study (panel A) and distribution of children who tested positive for SARS-CoV-2 with RT-PCR (panel B) from 1st March to 31st May 2020.

Significant differences in the positivity rate were also detected among different age groups (Table 1) (P-value: <0.0001). Adolescents of 11–16 years had the highest positivity rate (3.6%) followed by children of 6–10 years (1.9%), while children of 1–5 years had the lowest positivity rate (0.9%) (Table 1). Adolescents had a significantly higher relative risk (RR) for positive SARS-CoV-2 RT-PCR result when compared to younger children (RR = 2.62; 95% CI 1.73–3.97). However, since the testing rate significantly differed between age groups, the incidence of SARS-CoV-2 infection per age group was found highest in infants <1 year (Table 1).

Table 1. Number of children tested for SARS-CoV-2 with RT-PCR and confirmed infections per age group, Greece from 1st March to 31st May 2020

a Modified incidence was calculated based only on the index cases of SARS-CoV-2 in each age group.

The mean turnaround time for the SARS-CoV-2 RT-PCR result was 25.13 (s.d.: 17.47) h; in 21% of the hospitals (37/141 responses or 14/65 clinics) molecular testing was available within the facility. However, significant differences were detected between tertiary care and secondary care hospitals regarding turnaround time for the result (mean ± s.d.: 16.5 ± 11.34 vs. 30.94 ± 18.28 h, respectively, P-value: <0.0001). Significant differences were also detected between public and private hospitals regarding time to result (mean ± s.d.: 26.7 ± 17.57 vs. 13.4 ± 9.17 h respectively, P-value: 0.002), as well as regarding positivity rate (2.34%, 85/3620 vs. 0.39%, 5/1281, respectively, P-value: <0.001).

Among 90 children tested positive for SARS-CoV-2, 75 (83%) were hospitalised, while 1 (1.3%) toddler with spinal muscular atrophy required intensive care. Of them, 47 children represent a cluster from a Roma camp in Central Greece, who were isolated in a clinic, to prevent transmission to other family members. There was no death or SARS-CoV-2-associated multisystem inflammatory syndrome recorded.

A more detailed analysis included 1598 children, who were tested for SARS-CoV-2 in tertiary care hospitals in Athens and Thessaloniki and the reason for testing are presented in Table 2. The median age was 3 years (IQR: 0.7–9 years) and 58.6% of them were boys. Overall, 28 children (1.5%) tested positive; of them 19 had clinical manifestations and had presented with fever (65%), and/or respiratory symptoms (55%) and/or gastrointestinal symptoms (10%). No complications were reported in the hospitalised children with COVID-19, and almost all recovered with supportive care. Exception was one toddler with spinal muscular atrophy who was intubated and admitted to ICU, leading to respiratory insufficiency and tracheostomy, who was administered hydroxychloroquine, oseltamivir and corticosteroids. Six neonates of SARS-CoV-2 positive mothers were included in this subpopulation, all of whom tested negative.

Table 2. Aetiology for SARS-CoV-2 molecular testing in tertiary care paediatric departments in Athens (n = 3) and Thessaloniki (n = 1), 1st March—31st May 2020 (n = 1598)

Several children had more than one reasons for testing.

Discussion

In the current study, we detected a positivity rate for SARS-CoV-2 (1.8%) lower than the general population positivity rate (2.6%) in Greece during the same period [7]. Nevertheless, most SARS-CoV-2 paediatric cases were detected in specific geographical regions associated with local outbreaks. In the first phase of the pandemic, Greece reported lower incidence of COVID-19 when compared to most other European countries [8]. A possible explanation for the country's low incidence could be that early after the first SARS-CoV-2 adult case in Greece (25th February 2020), school closure (10th March) and community lock-down (16th March) were implemented. Whether school closure affected COVID-19 epidemic curve still remains controversial and challenging for the upcoming months, since the second phase of the epidemic is evolving [Reference Brooks9Reference Hildenwall12].

Similarly to our study, even in countries with high incidence of COVID-19, children were less affected [Reference Dong6, Reference Garazzino13, Reference Lu14]. This is probably due to the fact that children with SARS-CoV-2 infection are usually asymptomatic or have mild symptoms that do not require SARS-CoV-2 testing or hospitalisation [Reference Lu14Reference Zimmermann and Curtis16]. Thus, one may postulate that children presenting to the emergency department with mild symptoms were sent home without testing for SARS-CoV-2 or may have not visited healthcare centres at all. Consistent with recently published studies from other countries, only a small percentage of children were confirmed by RT-PCR and even smaller required hospital admission [Reference Gotzinger1, Reference Lu14, 17].

The strategy of testing only symptomatic children presenting to the hospital has recently been questioned based on a multicentre prospective French study [Reference Poline18]. A symptom-based SARS-CoV-2 testing strategy failed to identify 45% (95% CI 24–68) of hospitalised children infected by SARS-CoV-2. Based on these results authors recommended, in order to limit intra-hospital transmission, to consider a systematic screening of children admitted to hospital [Reference Poline18].

In our population, a higher testing and positivity rate of SARS-CoV-2 was detected in infants <1 year comparing with other age groups. All positive SARS-CoV-2 infants were associated with a positive family contact [Reference Maltezou19]. This was also found in other studies representing either more symptomatic disease in this age group, higher tendency of families to seek medical advice or higher propensity of clinicians to admit them to hospitals [Reference Garazzino13, 17]. In contrast, all six infants born from SARS-CoV-2 positive mothers were tested negative for the virus, as strict precautions were taken during labour. Although congenital infection with SARS-CoV-2 is not usual, there are case-reports of possible vertical transmission [Reference Marzollo20, Reference Yoon, Kang and Ahn21].

A limitation of the study is its retrospective nature; however, its major advantage is that it is presents nationwide data from a region that successfully coped with the SARS-CoV-2 virus during the initial phase of the pandemic. In addition, although no significant complications or adverse events were reported to children with COVID-19 in our population, the low number of infected children does not allow drawing certain inferences.

In conclusion, criteria for molecular testing in paediatric population in the first phase of SARS-CoV-2 pandemic included a variety of symptoms from upper and lower respiratory or gastrointestinal tract or asymptomatic tracing. However, significant variation in SARS-CoV-2 molecular testing positivity rate and incidence between age groups indicate discrepancies in clinical manifestations or risk factors among different age groups that shall be considered when ordering molecular testing. Prospective surveillance studies are essential to identify specific risk factors associated with specific age groups and optimise testing and management strategies in children.

Acknowledgements

We thank the paediatric staff members of all hospital paediatric departments around the country that responded to the questionnaire regarding SARS-CoV-2 molecular testing in their hospitals. The list of collaborators–institutions can be found here.

Data availability statement

Data included in this paper are available upon request to the corresponding author.

Footnotes

*

Equal contribution.

References

Gotzinger, F et al. (2020) COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child and Adolescent Health 4, 653661.CrossRefGoogle ScholarPubMed
Manti, S et al. (2020) SARS-CoV-2 infection in pediatric population. Acta Biomedica 91, e2020003.Google ScholarPubMed
Suratannon, N et al. (2020) COVID-19 in children: heterogeneity within the disease and hypothetical pathogenesis. Asian Pacific Journal of Allergy and Immunology 38, 170177.Google ScholarPubMed
Radia, T et al. (2020) Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatric Respiratory Reviews. doi: 10.1016/j.prrv.2020. 08.001.CrossRefGoogle ScholarPubMed
Feng, W et al. (2020) Molecular diagnosis of COVID-19: challenges and research needs. Analytical Chemistry 92, 1019610209.CrossRefGoogle ScholarPubMed
Dong, Y et al. (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145, e20200702.CrossRefGoogle ScholarPubMed
Greek National Public Health Organization. Daily report of COVID-19 epidemiological surveillance. Available at https://eody.gov.gr/wp-content/uploads/2020/06/covid-gr-daily-report-20200601.pdf (accessed 1 June 2020).Google Scholar
European Center for Diseases Control. COVID-19 situation update for the EU/EEA and the UK, as of 5 August 2020. Available at https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea (accessed 10 November 2020.Google Scholar
Brooks, SK et al. (2020) The impact of unplanned school closure on children's social contact: rapid evidence review. Eurosurveillance 25, 2000188.CrossRefGoogle ScholarPubMed
Viner, RM et al. (2021) Reopening schools during the COVID-19 pandemic: governments must balance the uncertainty and risks of reopening schools against the clear harms associated with prolonged closure. Archives of Disease in Childhood 106, 111113.CrossRefGoogle ScholarPubMed
Poletti, M and Raballo, A (2020) Letter to the editor: evidence on school closure and children's social contact: useful for coronavirus disease (COVID-19)? Eurosurveillance 25, 2000758.CrossRefGoogle ScholarPubMed
Hildenwall, H et al. (2020) Paediatric COVID-19 admissions in a region with open schools during the two first months of the pandemic. Acta Paediatrica. doi: 10.1111/apa.15432.CrossRefGoogle Scholar
Garazzino, S et al. (2020) Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Eurosurveillance 25, 2000600.CrossRefGoogle ScholarPubMed
Lu, X et al. (2020) SARS-CoV-2 infection in children. New England Journal of Medicine 382, 16631665.CrossRefGoogle ScholarPubMed
Ludvigsson, JF (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica 109, 10881095.CrossRefGoogle Scholar
Zimmermann, P and Curtis, N (2020) COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatric Infectious Diseases Journal 39, 469477.CrossRefGoogle ScholarPubMed
Center for Diseases Control (2020) Coronavirus disease 2019 in children – United States, February 12–April 2, 2020. Morbidity and Mortality Weekly Report 69, 422426.CrossRefGoogle Scholar
Poline, J et al. (2020) Systematic SARS-CoV-2 screening at hospital admission in children: a French prospective multicenter study. Clinical Infectious Diseases. doi: 10.1093/cid/ciaa1044.CrossRefGoogle ScholarPubMed
Maltezou, HC et al. (2021) Transmission dynamics of SARS‐CoV‐2 within families with children in Greece: A study of 23 clusters. Journal of Medical Virology 93, 14141420.CrossRefGoogle ScholarPubMed
Marzollo, R et al. (2020) Possible coronavirus disease 2019 pandemic and pregnancy: vertical transmission is not excluded. Pediatric Infectious Disease Journal 39, e261e262.CrossRefGoogle Scholar
Yoon, SH, Kang, JM and Ahn, JG (2020) Clinical outcomes of 201 neonates born to mothers with COVID-19: a systematic review. European Review for Medical and Pharmacological Sciences 24, 78047815.Google ScholarPubMed
Figure 0

Fig. 1. Geographical distribution of the paediatric departments (n = 65) which participated in the national Greek paediatric study (panel A) and distribution of children who tested positive for SARS-CoV-2 with RT-PCR (panel B) from 1st March to 31st May 2020.

Figure 1

Table 1. Number of children tested for SARS-CoV-2 with RT-PCR and confirmed infections per age group, Greece from 1st March to 31st May 2020

Figure 2

Table 2. Aetiology for SARS-CoV-2 molecular testing in tertiary care paediatric departments in Athens (n = 3) and Thessaloniki (n = 1), 1st March—31st May 2020 (n = 1598)